PEAK6 Investments’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$549K Buy
+79,100
New +$621K ﹤0.01% 2258
2023
Q4
Sell
-17,500
Closed -$98.5K 4437
2023
Q3
$98.5K Buy
+17,500
New +$117K ﹤0.01% 3403
2023
Q1
Sell
-79,800
Closed -$372K 4521
2022
Q4
$372K Sell
79,800
-4,600
-5% -$22.7K ﹤0.01% 2772
2022
Q3
$394K Sell
84,400
-105,000
-55% -$662K ﹤0.01% 3101
2022
Q2
$1.12M Sell
189,400
-24,300
-11% -$270K ﹤0.01% 2960
2022
Q1
$4.13M Buy
213,700
+173,700
+434% +$3.98M 0.01% 1243
2021
Q4
$1.31M Sell
40,000
-171,000
-81% -$6.88M ﹤0.01% 2315
2021
Q3
$8.65M Sell
211,000
-4,500
-2% -$163K 0.02% 788
2021
Q2
$7.76M Buy
215,500
+194,200
+912% +$7.17M 0.02% 818
2021
Q1
$831K Buy
+21,300
New +$958K ﹤0.01% 2733

Other funds holding GDRX

PEAK6 Investments's GDRX Position: Q4 2023 in Review

PEAK6 Investments sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 51,643 shares — an estimated $291K sold.

PEAK6 Investments first reported a position in GDRX in Q1 2021 and held it in 11 quarters. The position peaked at $3.43M in Q1 2021. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

  • PEAK6 Investments reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 51,643 GoodRx Holdings shares in Q4 2023, an estimated $291K.
  • PEAK6 Investments first reported a position in GoodRx Holdings in Q1 2021 and held it in 11 quarters.
  • PEAK6 Investments's GoodRx Holdings position peaked at $3.43M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.